Introduction
============

Although poor premorbid intelligence among subjects with schizophrenia is a consistent finding ([@b24-ndt-4-1241]), there are still some controversies about its diagnostic specificity. There are few data on premorbid cognitive functioning in subjects with diagnoses other than schizophrenia, reporting conflicting results. [@b3-ndt-4-1241] reported subjects with schizophrenia more impaired on premorbid IQ scores than those suffering from affective disorders. In a prospective study, [@b21-ndt-4-1241] demonstrated that subjects with chronic affective illnesses were more cognitively impaired during childhood and adolescence than controls. Others studies have shown no or few differences between subjects with schizophrenia and non-psychotic psychiatric disorders ([@b8-ndt-4-1241]).

More recently [@b11-ndt-4-1241] reported that schizophrenia and related disorders, other psychotic disorders, adjustment, personality, alcohol and substance use related disorders but not mood disorders as well as neuroses and related disorders were significantly associated with low IQ scores. On the other hand, results of [@b20-ndt-4-1241] indicate that premorbid intellectual ability, in terms of visuospatial reasoning, is impaired in bipolar disorder and schizophrenia and, to a smaller extent, in other psychoses suggesting a possible shared aetiology.

Several studies finally report that the association between cognitive deficits and functional impairment may exist across most diagnostic entities ([@b25-ndt-4-1241]; [@b23-ndt-4-1241]).

There is therefore a rationale for further studies examining whether low IQ test scores are specifically associated with schizophrenia or are a marker of increased vulnerability to the development of a broader range of psychiatric disorders.

In the present study we aimed to investigate the premorbid intelligence level across diagnoses in psychiatric patients during an index admission. Lacking IQ evaluations before the illness onset, we used the 'Test di Intelligenza Breve' (TIB), Italian adaptation of the National Adult Reading Test (NART) ([@b17-ndt-4-1241]; [@b14-ndt-4-1241]). This instrument is based on reading task, considered a valid and clinically useful method to investigate premorbid intellectual abilities ([@b4-ndt-4-1241]; [@b6-ndt-4-1241]; [@b19-ndt-4-1241]).

Method
======

Clinical sample
---------------

Consecutively admitted patients to Villa Serena Medical Centre, Psychiatry Unit, Città S. Angelo (Italy) were included if they fulfilled the following criteria: 1) informed consent to participate in the study; 2) less than 55 years of age; and 3) no history of organic brain disease, 4) mood, personality and schizophrenic disorders. Subjects were diagnosed according to DSM-IV criteria and all available clinical and historical information collected during the hospital stay, by two senior psychiatrists (AR and PS), who personally interviewed the patients.

The local Ethics Committee approved the study procedures. All subjects entering the protocol provided informed consent after receiving a complete description of the study.

A total of 273 subjects were enrolled in the study: 79 (28.94%) women and 194 men, with a mean age of 43.31 years (SD 13.97). Educational level was 9.92 (SD 3.84). DSM-IV diagnoses were personality disorder (N = 56), depressive disorder (N = 51), bipolar disorder (N = 64), schizophrenic disorder (N = 102).

Because of high cluster A, B and C comorbidity, we decided to group personality disorders together. No other diagnoses were a priori considered for IQ evaluation in so far as only marginally represented among inpatient sample. The referral centre does not admit dual diagnoses.

Control subjects
----------------

Control subjects were recruited from the local community \[81 subjects, 50 women and 31 men; mean age 40.42 (SD 9.26), educational level 12.51 (SD 3.32)\].

Because the patient group may have had a decline in cognitive function, an effort was made to match patient and control groups as closely as possible on age and socioeconomic status. Thus, the control data provide an estimate of the cognitive function level expected in individuals with the same socioeconomic background of the patient group.

Procedure
---------

Subjects were tested using the 'Test di Intelligenza Breve' (TIB) ([@b17-ndt-4-1241]) just before discharge, in a remission phase. The TIB consists of 54 words (34 effective test-words with irregular accent and 20 control-words with high frequency of use), that subjects have to read and pronounce. The total number of mistakes of reading defines the TIB error score. The estimated IQ scores (ie, performance, verbal and total) are calculated through the regression of equations taking into account sex, age and educational level: estimated performance IQ = (0.194 × age) + (−1.154 × TIB errors) + 107.364; estimated verbal IQ = (4.198 × sex F = 0 M = 1) + (0.938 × educational level) + (−0.893 × TIB errors) + 99.536; estimated total IQ = (0.659 × educational level) + (−0.947 × TIB errors) + 107.58.

The Clinical Global Impression-Severity (CGI-S) ([@b7-ndt-4-1241]) and the Global Assessment of Functioning (GAF) Scale (DSM IV, Axis V, [@b1-ndt-4-1241]) for the assessment of the psychological, social, and occupational functioning were obtained for patient groups.

Results
=======

Sex distribution was different, but no between sex comparisons reached significance. No differences in age and educational level were seen among the four clinical groups. No differences for age between clinical sample and healthy subjects were seen. However controls were more educated ([Table 1](#t1-ndt-4-1241){ref-type="table"}).

The data of the clinical as well as the control samples were appreciably normally distributed (Kolmogorov-Smirnov tests from 0.65 to 1.18, all not significant). One way ANOVAs on estimated IQs showed significant differences between the clinical samples and the control subjects (Scheffé tests all significant at 0.0005 level), without any difference between them ([Table 1](#t1-ndt-4-1241){ref-type="table"}).

Correlations among educational level and estimated IQs have been performed: educational level vs Total IQ r = 0.83, vs Performance IQ r = 0.65; vs Verbal IQ r = 0.84, all p \< 0.0005. Although educational level was included in the estimated IQs calculation, we tentatively considered this variable as covariate. No differences were seen among the clinical samples and IQs remained significantly different between patients and controls ([Table 1](#t1-ndt-4-1241){ref-type="table"}).

CGI and GAF evaluations were performed to get more information on the clinical variability: subjects with schizophrenia only differed from the other samples with more severe disorder and impaired functioning ([Table 1](#t1-ndt-4-1241){ref-type="table"}).

Discussion
==========

The lack of premorbid IQ level specificity among different diagnoses, such as schizophrenia, affective and personality disorders confirms results of recent studies ([@b25-ndt-4-1241]; [@b23-ndt-4-1241]; [@b11-ndt-4-1241]).

These data suggest a vulnerability diathesis likely having a neurodevelopmental origin such as sub optimal brain development. This vulnerability diathesis can lead to a mental disorder due to attentional difficulties, distorted perceptions and cognitive interpretation of stimuli which is precipitated possibly by distressing events leading to unusual thought processes, decreased empathic ability and social functioning ([@b12-ndt-4-1241]).

Even though we are aware that other factors could have influenced IQ performance (ie, medication, time of testing), we attempted to consider the role of general factors affecting clinical outcome using CGI-S and GAF. Subjects with schizophrenia did have a more severe disorder but similar to other groups premorbid IQ. Different genetic and environmental factors interacting with premorbid IQ can orient towards different phenotypical outcomes (ie, diagnoses, severity of illness, global functioning) ([@b5-ndt-4-1241]).

However, premorbid IQ is associated with poorer outcome and higher mortality ([@b13-ndt-4-1241]; [@b2-ndt-4-1241]) and it has also been shown to have a pathoplastic effect on symptom presentation in functional psychoses ([@b19-ndt-4-1241]), ie, influencing the symptom expression during an index episode. The premorbid IQ, among other factors, could therefore affect this 'intermediate outcome' and, having an effect on symptomatology, obscure diagnostic boundary.

The lack of inclusion of patients with other diagnoses limits the conclusions of this study to the sample described. The role of premorbid IQ in outpatients with other diagnoses deserves further investigation.

Although not surprising and not the primary aim of the study, the observation of a difference between controls and patients deserves some comments.

Several reasons could lead to overestimate a between group difference. The choice of a not adequate control sample could be the first. Although we selected a control group of similar age, socioeconomic status and environment, the educational level was different.

The relevance of educational level to neurocognitive measures has been widely discussed in the literature ([@b18-ndt-4-1241]). It is conceivable that the illness onset could limit further achievement, thus contaminating the measure of educational level. Equating patients and controls on a variable (ie, educational level) that is descriptive of the disease outcome process may lead to a 'matching fallacy' (Meheel 1970), with the risk of biased comparisons, contrasting overachieving patients with underachieving controls ([@b16-ndt-4-1241]).

However, when educational level was controlled by covariance, results were similar and, above all, no differences among patients emerged. Moreover the data we reported are in line with those of premorbid IQ estimated in similar control samples obtained by different tools: TIB ([@b17-ndt-4-1241]), NART (eg, [@b9-ndt-4-1241]), WAIS-R (eg, [@b15-ndt-4-1241]). It could be possible that recruiting admitted patients produces a bias with less severe patients and putatively less impaired IQ excluded: if subjects with low IQ are more likely than subjects with high IQ to be admitted to hospital, an overestimation of an association between low IQ and disorder could occur. However [@b25-ndt-4-1241] did not find association between IQ and illness severity but we reported that premorbid IQ could influence symptoms presentation ([@b19-ndt-4-1241]).

On the other hand the differences between patients and controls could be underestimated: tests of reading ability (eg, NART) provide an accurate estimate of premorbid IQ for individuals in the average range of intelligence, while it appears of relatively lower utility for individuals at the lower end of IQ range due to the overestimation of their performance ([@b6-ndt-4-1241]).

Preventive intervention on more susceptible people could be an important aim, and evaluation of cognitive abilities in adolescence or early adulthood a useful tool to identify at risk individuals ([@b22-ndt-4-1241]).
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Socio-demographic, clinical characteristics and estimated IQs in the clinical samples and in control subjects \[mean (SD)\]

                                                             N     Age             Educational level                                       CGI-S                                                    GAF                                                      Total IQ                                                Verbal IQ                                               Perfor-mance IQ
  ---------------------------------------------------------- ----- --------------- ------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  Personality disorders                                      56    40.81 (10.38)   8.91 (3.51)                                             3.9 (1.2)                                                66.0 (12.0)                                              100.14 (9.64)                                           98.79 (10.36)                                           99.06 (9.39)
  Depressive disorder                                        51    46.77 (14.42)   8.33 (4.06)                                             3.5 (0.9)                                                70.0 (9.1)                                               100.11 (11.61)                                          97.68 (12.86)                                           100.64 (9.95)
  Bipolar disorder                                           64    43.88 (12.52)   9.60 (3.93)                                             3.7 (1.0)                                                65.9 (10.5)                                              101.76 (10.61)                                          99.58 (11.51)                                           101.07 (10.48)
  Schizophrenic disorder                                     102   42.60 (15.99)   9.79 (3.77)                                             4.5 (1.2)                                                55.8 (12.5)                                              102.12 (10.32)                                          100.74 (10.80)                                          101.11 (10.17)
  Control subjects                                           81    40.42 (9.26)    12.51 (3.32)                                                                                                                                                              111.20 (5.40)                                           109.58 (6.78)                                           109.44 (4.56)
  One way ANOVA                                                    F = 2.30        F = 13.25                                               F = 12.18                                                F = 22.75                                                F = 17.45                                               F = 15.41                                               F = 15.41
                                                                   NS              p \< 0.0005[§](#tfn3-ndt-4-1241){ref-type="table-fn"}   p \< 0.0005[\*](#tfn2-ndt-4-1241){ref-type="table-fn"}   p \< 0.0005[\*](#tfn2-ndt-4-1241){ref-type="table-fn"}   p \< 0.0005[§](#tfn3-ndt-4-1241){ref-type="table-fn"}   p \< 0.0005[§](#tfn3-ndt-4-1241){ref-type="table-fn"}   p \< 0.0005[§](#tfn3-ndt-4-1241){ref-type="table-fn"}
  One way ANCOVA[+](#tfn4-ndt-4-1241){ref-type="table-fn"}                                                                                                                                                                                                   F = 5.03                                                F = 3.09                                                F = 5.26
                                                                                                                                                                                                                                                             p \< 0.001                                              p \< 0.025                                              p \< 0.005
  Regression analysis for covariates                                                                                                                                                                                                                                                                                                                                         
  Educational level                                                                                                                                                                                                                                          t = 25.72                                               t = 26.78                                               t = 14.27
                                                                                                                                                                                                                                                             p \< 0.0005                                             p \< 0.0005                                             p \< 0.0005

Scheffé tests.

Subjects with schizophrenia vs the other clinical groups differ at a 0.05 level (d.f. 3.272).

Clinical samples vs control subjects: all significant at a 0.0005 level (d.f. 4,353).

Educational level as covariate (d.f. 4,353).
